ABCELLERA BIOLOGICS Tangible Net Worth Ratio
ABCELLERA BIOLOGICS tangible net worth ratio. ABCELLERA BIOLOGICS (8QQ) has a Tangible Net Worth Ratio of 95.9% as of June 2026. This metric is calculated by deducting intangible assets (€36.53 Million) from net assets (€896.02 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check ABCELLERA BIOLOGICS (8QQ) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of ABCELLERA BIOLOGICS (2021–2025)
Tangible net worth ratio of ABCELLERA BIOLOGICS from 2021 to 2025. This chart shows how ABCELLERA BIOLOGICS's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 95.9%, reflecting net assets of €896.02 Million with intangible assets of €36.53 Million EUR. See 8QQ net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
ABCELLERA BIOLOGICS Tangible Net Worth Ratio by Year (2021–2025)
ABCELLERA BIOLOGICS tangible net worth ratio by year from 2021 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for ABCELLERA BIOLOGICS from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ABCELLERA BIOLOGICS market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.0% | €966.90 Million | €38.38 Million | €1.36 Billion | ▲ +0.0 pp |
| 2024 | 96.0% | €1.06 Billion | €42.11 Million | €1.36 Billion | ▲ +6.5 pp |
| 2023 | 89.5% | €1.15 Billion | €120.42 Million | €1.49 Billion | ▲ +0.2 pp |
| 2022 | 89.3% | €1.23 Billion | €131.50 Million | €1.54 Billion | ▲ +3.8 pp |
| 2021 | 85.5% | €1.03 Billion | €148.39 Million | €1.32 Billion | — |